Rising demand for non-surgical injectables propels Indian aesthetics market

The Indian aesthetics market is set for significant growth driven by injectable non-surgical cosmetics. Predictions from Global Data indicate a projected CAGR of over 5 per cent by 2030, attributing this expansion to the increasing demand for aesthetic injectables. These injectables, including botulinum toxin, hyaluronic acid, and non-hyaluronic acid fillers, are gaining popularity due to their non-invasive nature, eliminating the need for surgical procedures.

Ayshi Ganguly, Medical Devices Analyst at GlobalData, underscores the effectiveness, safety, and swift recovery associated with these treatments. The pandemic has heightened skin consciousness among individuals, leading to a preference for non-invasive treatments. These procedures offer rejuvenation, hydration, and plumpness without the requirement for surgery.The availability of a broader range of injectable fillers, technological advancements such as virtual reality and AI for personalized skin recommendations, and enhanced post-surgery monitoring have attracted more customers. These developments indicate the potential for further market expansion.

This article appears in the AMI Dec-Jan Edition Issue of Aesthetic Medicine India

Click here to view the article in the magazine.
To view other articles in this issue Click here.
If you would like to view other issues of Aesthetic Medicine India, you can see the full archive here.

COPIED
This article appears in the AMI Dec-Jan Edition Issue of Aesthetic Medicine India